aluates Reports

$ 0.0

Automative

Global SGLT2 Inhibitor Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-2R9930

Global SGLT2 Inhibitor Market Insights Forecast to 2028

BUY CHAPTERS

Global SGLT2 Inhibitor Market Insights, Forecast to 2030

Code: QYRE-Auto-2R9930

Report

December 2024

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

SGLT2 Inhibitor Market

The global SGLT2 Inhibitor market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for SGLT2 Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for SGLT2 Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for SGLT2 Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of SGLT2 Inhibitor include Eli Lilly, Boehringer Ingelheim, Johnson & Johnson, AstraZeneca, Merck and Pfizer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Covers:

This report presents an overview of global market for SGLT2 Inhibitor, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of SGLT2 Inhibitor, also provides the sales of main regions and countries. Highlights of the upcoming market potential for SGLT2 Inhibitor, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the SGLT2 Inhibitor sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global SGLT2 Inhibitor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for SGLT2 Inhibitor sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of SGLT2 Inhibitor Market Report

Report Metric	Details
Report Name	SGLT2 Inhibitor Market
Segment by Type	Dapagliflozin Canagliflozin Empagliflozin Other
Segment by Application	Hospital Pharmacies Retail Pharmacies
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson, AstraZeneca, Merck, Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of SGLT2 Inhibitor in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of SGLT2 Inhibitor manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, SGLT2 Inhibitor sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the SGLT2 Inhibitor Market report?

Ans: The main players in the SGLT2 Inhibitor Market are Johnson & Johnson, AstraZeneca, Merck, Pfizer

What are the Application segmentation covered in the SGLT2 Inhibitor Market report?

Ans: The Applications covered in the SGLT2 Inhibitor Market report are Hospital Pharmacies, Retail Pharmacies

What are the Type segmentation covered in the SGLT2 Inhibitor Market report?

Ans: The Types covered in the SGLT2 Inhibitor Market report are Dapagliflozin, Canagliflozin, Empagliflozin, Other

1 Study Coverage

1.1 SGLT2 Inhibitor Product Introduction

1.2 Market by Type

1.2.1 Global SGLT2 Inhibitor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Dapagliflozin

1.2.3 Canagliflozin

1.2.4 Empagliflozin

1.2.5 Other

1.3 Market by Application

1.3.1 Global SGLT2 Inhibitor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global SGLT2 Inhibitor Sales Estimates and Forecasts 2019-2030

2.2 Global SGLT2 Inhibitor Revenue by Region

2.2.1 Global SGLT2 Inhibitor Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global SGLT2 Inhibitor Revenue by Region (2019-2024)

2.2.3 Global SGLT2 Inhibitor Revenue by Region (2025-2030)

2.2.4 Global SGLT2 Inhibitor Revenue Market Share by Region (2019-2030)

2.3 Global SGLT2 Inhibitor Sales Estimates and Forecasts 2019-2030

2.4 Global SGLT2 Inhibitor Sales by Region

2.4.1 Global SGLT2 Inhibitor Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global SGLT2 Inhibitor Sales by Region (2019-2024)

2.4.3 Global SGLT2 Inhibitor Sales by Region (2025-2030)

2.4.4 Global SGLT2 Inhibitor Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global SGLT2 Inhibitor Sales by Manufacturers

3.1.1 Global SGLT2 Inhibitor Sales by Manufacturers (2019-2024)

3.1.2 Global SGLT2 Inhibitor Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of SGLT2 Inhibitor in 2023

3.2 Global SGLT2 Inhibitor Revenue by Manufacturers

3.2.1 Global SGLT2 Inhibitor Revenue by Manufacturers (2019-2024)

3.2.2 Global SGLT2 Inhibitor Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by SGLT2 Inhibitor Revenue in 2023

3.3 Global Key Players of SGLT2 Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global SGLT2 Inhibitor Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global SGLT2 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of SGLT2 Inhibitor, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of SGLT2 Inhibitor, Product Offered and Application

3.8 Global Key Manufacturers of SGLT2 Inhibitor, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global SGLT2 Inhibitor Sales by Type

4.1.1 Global SGLT2 Inhibitor Historical Sales by Type (2019-2024)

4.1.2 Global SGLT2 Inhibitor Forecasted Sales by Type (2025-2030)

4.1.3 Global SGLT2 Inhibitor Sales Market Share by Type (2019-2030)

4.2 Global SGLT2 Inhibitor Revenue by Type

4.2.1 Global SGLT2 Inhibitor Historical Revenue by Type (2019-2024)

4.2.2 Global SGLT2 Inhibitor Forecasted Revenue by Type (2025-2030)

4.2.3 Global SGLT2 Inhibitor Revenue Market Share by Type (2019-2030)

4.3 Global SGLT2 Inhibitor Price by Type

4.3.1 Global SGLT2 Inhibitor Price by Type (2019-2024)

4.3.2 Global SGLT2 Inhibitor Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global SGLT2 Inhibitor Sales by Application

5.1.1 Global SGLT2 Inhibitor Historical Sales by Application (2019-2024)

5.1.2 Global SGLT2 Inhibitor Forecasted Sales by Application (2025-2030)

5.1.3 Global SGLT2 Inhibitor Sales Market Share by Application (2019-2030)

5.2 Global SGLT2 Inhibitor Revenue by Application

5.2.1 Global SGLT2 Inhibitor Historical Revenue by Application (2019-2024)

5.2.2 Global SGLT2 Inhibitor Forecasted Revenue by Application (2025-2030)

5.2.3 Global SGLT2 Inhibitor Revenue Market Share by Application (2019-2030)

5.3 Global SGLT2 Inhibitor Price by Application

5.3.1 Global SGLT2 Inhibitor Price by Application (2019-2024)

5.3.2 Global SGLT2 Inhibitor Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada SGLT2 Inhibitor Market Size by Type

6.1.1 US & Canada SGLT2 Inhibitor Sales by Type (2019-2030)

6.1.2 US & Canada SGLT2 Inhibitor Revenue by Type (2019-2030)

6.2 US & Canada SGLT2 Inhibitor Market Size by Application

6.2.1 US & Canada SGLT2 Inhibitor Sales by Application (2019-2030)

6.2.2 US & Canada SGLT2 Inhibitor Revenue by Application (2019-2030)

6.3 US & Canada SGLT2 Inhibitor Market Size by Country

6.3.1 US & Canada SGLT2 Inhibitor Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada SGLT2 Inhibitor Sales by Country (2019-2030)

6.3.3 US & Canada SGLT2 Inhibitor Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe SGLT2 Inhibitor Market Size by Type

7.1.1 Europe SGLT2 Inhibitor Sales by Type (2019-2030)

7.1.2 Europe SGLT2 Inhibitor Revenue by Type (2019-2030)

7.2 Europe SGLT2 Inhibitor Market Size by Application

7.2.1 Europe SGLT2 Inhibitor Sales by Application (2019-2030)

7.2.2 Europe SGLT2 Inhibitor Revenue by Application (2019-2030)

7.3 Europe SGLT2 Inhibitor Market Size by Country

7.3.1 Europe SGLT2 Inhibitor Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe SGLT2 Inhibitor Sales by Country (2019-2030)

7.3.3 Europe SGLT2 Inhibitor Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China SGLT2 Inhibitor Market Size

8.1.1 China SGLT2 Inhibitor Sales (2019-2030)

8.1.2 China SGLT2 Inhibitor Revenue (2019-2030)

8.2 China SGLT2 Inhibitor Market Size by Application

8.2.1 China SGLT2 Inhibitor Sales by Application (2019-2030)

8.2.2 China SGLT2 Inhibitor Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia SGLT2 Inhibitor Market Size by Type

9.1.1 Asia SGLT2 Inhibitor Sales by Type (2019-2030)

9.1.2 Asia SGLT2 Inhibitor Revenue by Type (2019-2030)

9.2 Asia SGLT2 Inhibitor Market Size by Application

9.2.1 Asia SGLT2 Inhibitor Sales by Application (2019-2030)

9.2.2 Asia SGLT2 Inhibitor Revenue by Application (2019-2030)

9.3 Asia SGLT2 Inhibitor Sales by Region

9.3.1 Asia SGLT2 Inhibitor Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia SGLT2 Inhibitor Revenue by Region (2019-2030)

9.3.3 Asia SGLT2 Inhibitor Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America SGLT2 Inhibitor Market Size by Type

10.1.1 Middle East, Africa and Latin America SGLT2 Inhibitor Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America SGLT2 Inhibitor Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America SGLT2 Inhibitor Market Size by Application

10.2.1 Middle East, Africa and Latin America SGLT2 Inhibitor Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America SGLT2 Inhibitor Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America SGLT2 Inhibitor Sales by Country

10.3.1 Middle East, Africa and Latin America SGLT2 Inhibitor Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America SGLT2 Inhibitor Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America SGLT2 Inhibitor Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Eli Lilly

11.1.1 Eli Lilly Company Information

11.1.2 Eli Lilly Overview

11.1.3 Eli Lilly SGLT2 Inhibitor Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Eli Lilly SGLT2 Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Eli Lilly Recent Developments

11.2 Boehringer Ingelheim

11.2.1 Boehringer Ingelheim Company Information

11.2.2 Boehringer Ingelheim Overview

11.2.3 Boehringer Ingelheim SGLT2 Inhibitor Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Boehringer Ingelheim SGLT2 Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Boehringer Ingelheim Recent Developments

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Information

11.3.2 Johnson & Johnson Overview

11.3.3 Johnson & Johnson SGLT2 Inhibitor Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Johnson & Johnson SGLT2 Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Johnson & Johnson Recent Developments

11.4 AstraZeneca

11.4.1 AstraZeneca Company Information

11.4.2 AstraZeneca Overview

11.4.3 AstraZeneca SGLT2 Inhibitor Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 AstraZeneca SGLT2 Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 AstraZeneca Recent Developments

11.5 Merck

11.5.1 Merck Company Information

11.5.2 Merck Overview

11.5.3 Merck SGLT2 Inhibitor Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Merck SGLT2 Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Merck Recent Developments

11.6 Pfizer

11.6.1 Pfizer Company Information

11.6.2 Pfizer Overview

11.6.3 Pfizer SGLT2 Inhibitor Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Pfizer SGLT2 Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Pfizer Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 SGLT2 Inhibitor Industry Chain Analysis

12.2 SGLT2 Inhibitor Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 SGLT2 Inhibitor Production Mode & Process

12.4 SGLT2 Inhibitor Sales and Marketing

12.4.1 SGLT2 Inhibitor Sales Channels

12.4.2 SGLT2 Inhibitor Distributors

12.5 SGLT2 Inhibitor Customers

13 Market Dynamics

13.1 SGLT2 Inhibitor Industry Trends

13.2 SGLT2 Inhibitor Market Drivers

13.3 SGLT2 Inhibitor Market Challenges

13.4 SGLT2 Inhibitor Market Restraints

14 Key Findings in The Global SGLT2 Inhibitor Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global SGLT2 Inhibitor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Dapagliflozin

Table 3. Major Manufacturers of Canagliflozin

Table 4. Major Manufacturers of Empagliflozin

Table 5. Major Manufacturers of Other

Table 6. Global SGLT2 Inhibitor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global SGLT2 Inhibitor Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global SGLT2 Inhibitor Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global SGLT2 Inhibitor Revenue by Region (2025-2030) & (US$ Million)

Table 10. Global SGLT2 Inhibitor Revenue Market Share by Region (2019-2024)

Table 11. Global SGLT2 Inhibitor Revenue Market Share by Region (2025-2030)

Table 12. Global SGLT2 Inhibitor Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 13. Global SGLT2 Inhibitor Sales by Region (2019-2024) & (Kg)

Table 14. Global SGLT2 Inhibitor Sales by Region (2025-2030) & (Kg)

Table 15. Global SGLT2 Inhibitor Sales Market Share by Region (2019-2024)

Table 16. Global SGLT2 Inhibitor Sales Market Share by Region (2025-2030)

Table 17. Global SGLT2 Inhibitor Sales by Manufacturers (2019-2024) & (Kg)

Table 18. Global SGLT2 Inhibitor Sales Share by Manufacturers (2019-2024)

Table 19. Global SGLT2 Inhibitor Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 20. Global SGLT2 Inhibitor Revenue Share by Manufacturers (2019-2024)

Table 21. Global Key Players of SGLT2 Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024

Table 22. SGLT2 Inhibitor Price by Manufacturers 2019-2024 (USD/g)

Table 23. Global SGLT2 Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global SGLT2 Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SGLT2 Inhibitor as of 2023)

Table 25. Global Key Manufacturers of SGLT2 Inhibitor, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of SGLT2 Inhibitor, Product Offered and Application

Table 27. Global Key Manufacturers of SGLT2 Inhibitor, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global SGLT2 Inhibitor Sales by Type (2019-2024) & (Kg)

Table 30. Global SGLT2 Inhibitor Sales by Type (2025-2030) & (Kg)

Table 31. Global SGLT2 Inhibitor Sales Share by Type (2019-2024)

Table 32. Global SGLT2 Inhibitor Sales Share by Type (2025-2030)

Table 33. Global SGLT2 Inhibitor Revenue by Type (2019-2024) & (US$ Million)

Table 34. Global SGLT2 Inhibitor Revenue by Type (2025-2030) & (US$ Million)

Table 35. Global SGLT2 Inhibitor Revenue Share by Type (2019-2024)

Table 36. Global SGLT2 Inhibitor Revenue Share by Type (2025-2030)

Table 37. SGLT2 Inhibitor Price by Type (2019-2024) & (USD/g)

Table 38. Global SGLT2 Inhibitor Price Forecast by Type (2025-2030) & (USD/g)

Table 39. Global SGLT2 Inhibitor Sales by Application (2019-2024) & (Kg)

Table 40. Global SGLT2 Inhibitor Sales by Application (2025-2030) & (Kg)

Table 41. Global SGLT2 Inhibitor Sales Share by Application (2019-2024)

Table 42. Global SGLT2 Inhibitor Sales Share by Application (2025-2030)

Table 43. Global SGLT2 Inhibitor Revenue by Application (2019-2024) & (US$ Million)

Table 44. Global SGLT2 Inhibitor Revenue by Application (2025-2030) & (US$ Million)

Table 45. Global SGLT2 Inhibitor Revenue Share by Application (2019-2024)

Table 46. Global SGLT2 Inhibitor Revenue Share by Application (2025-2030)

Table 47. SGLT2 Inhibitor Price by Application (2019-2024) & (USD/g)

Table 48. Global SGLT2 Inhibitor Price Forecast by Application (2025-2030) & (USD/g)

Table 49. US & Canada SGLT2 Inhibitor Sales by Type (2019-2024) & (Kg)

Table 50. US & Canada SGLT2 Inhibitor Sales by Type (2025-2030) & (Kg)

Table 51. US & Canada SGLT2 Inhibitor Revenue by Type (2019-2024) & (US$ Million)

Table 52. US & Canada SGLT2 Inhibitor Revenue by Type (2025-2030) & (US$ Million)

Table 53. US & Canada SGLT2 Inhibitor Sales by Application (2019-2024) & (Kg)

Table 54. US & Canada SGLT2 Inhibitor Sales by Application (2025-2030) & (Kg)

Table 55. US & Canada SGLT2 Inhibitor Revenue by Application (2019-2024) & (US$ Million)

Table 56. US & Canada SGLT2 Inhibitor Revenue by Application (2025-2030) & (US$ Million)

Table 57. US & Canada SGLT2 Inhibitor Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 58. US & Canada SGLT2 Inhibitor Revenue by Country (2019-2024) & (US$ Million)

Table 59. US & Canada SGLT2 Inhibitor Revenue by Country (2025-2030) & (US$ Million)

Table 60. US & Canada SGLT2 Inhibitor Sales by Country (2019-2024) & (Kg)

Table 61. US & Canada SGLT2 Inhibitor Sales by Country (2025-2030) & (Kg)

Table 62. Europe SGLT2 Inhibitor Sales by Type (2019-2024) & (Kg)

Table 63. Europe SGLT2 Inhibitor Sales by Type (2025-2030) & (Kg)

Table 64. Europe SGLT2 Inhibitor Revenue by Type (2019-2024) & (US$ Million)

Table 65. Europe SGLT2 Inhibitor Revenue by Type (2025-2030) & (US$ Million)

Table 66. Europe SGLT2 Inhibitor Sales by Application (2019-2024) & (Kg)

Table 67. Europe SGLT2 Inhibitor Sales by Application (2025-2030) & (Kg)

Table 68. Europe SGLT2 Inhibitor Revenue by Application (2019-2024) & (US$ Million)

Table 69. Europe SGLT2 Inhibitor Revenue by Application (2025-2030) & (US$ Million)

Table 70. Europe SGLT2 Inhibitor Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 71. Europe SGLT2 Inhibitor Revenue by Country (2019-2024) & (US$ Million)

Table 72. Europe SGLT2 Inhibitor Revenue by Country (2025-2030) & (US$ Million)

Table 73. Europe SGLT2 Inhibitor Sales by Country (2019-2024) & (Kg)

Table 74. Europe SGLT2 Inhibitor Sales by Country (2025-2030) & (Kg)

Table 75. China SGLT2 Inhibitor Sales by Type (2019-2024) & (Kg)

Table 76. China SGLT2 Inhibitor Sales by Type (2025-2030) & (Kg)

Table 77. China SGLT2 Inhibitor Revenue by Type (2019-2024) & (US$ Million)

Table 78. China SGLT2 Inhibitor Revenue by Type (2025-2030) & (US$ Million)

Table 79. China SGLT2 Inhibitor Sales by Application (2019-2024) & (Kg)

Table 80. China SGLT2 Inhibitor Sales by Application (2025-2030) & (Kg)

Table 81. China SGLT2 Inhibitor Revenue by Application (2019-2024) & (US$ Million)

Table 82. China SGLT2 Inhibitor Revenue by Application (2025-2030) & (US$ Million)

Table 83. Asia SGLT2 Inhibitor Sales by Type (2019-2024) & (Kg)

Table 84. Asia SGLT2 Inhibitor Sales by Type (2025-2030) & (Kg)

Table 85. Asia SGLT2 Inhibitor Revenue by Type (2019-2024) & (US$ Million)

Table 86. Asia SGLT2 Inhibitor Revenue by Type (2025-2030) & (US$ Million)

Table 87. Asia SGLT2 Inhibitor Sales by Application (2019-2024) & (Kg)

Table 88. Asia SGLT2 Inhibitor Sales by Application (2025-2030) & (Kg)

Table 89. Asia SGLT2 Inhibitor Revenue by Application (2019-2024) & (US$ Million)

Table 90. Asia SGLT2 Inhibitor Revenue by Application (2025-2030) & (US$ Million)

Table 91. Asia SGLT2 Inhibitor Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 92. Asia SGLT2 Inhibitor Revenue by Region (2019-2024) & (US$ Million)

Table 93. Asia SGLT2 Inhibitor Revenue by Region (2025-2030) & (US$ Million)

Table 94. Asia SGLT2 Inhibitor Sales by Region (2019-2024) & (Kg)

Table 95. Asia SGLT2 Inhibitor Sales by Region (2025-2030) & (Kg)

Table 96. Middle East, Africa and Latin America SGLT2 Inhibitor Sales by Type (2019-2024) & (Kg)

Table 97. Middle East, Africa and Latin America SGLT2 Inhibitor Sales by Type (2025-2030) & (Kg)

Table 98. Middle East, Africa and Latin America SGLT2 Inhibitor Revenue by Type (2019-2024) & (US$ Million)

Table 99. Middle East, Africa and Latin America SGLT2 Inhibitor Revenue by Type (2025-2030) & (US$ Million)

Table 100. Middle East, Africa and Latin America SGLT2 Inhibitor Sales by Application (2019-2024) & (Kg)

Table 101. Middle East, Africa and Latin America SGLT2 Inhibitor Sales by Application (2025-2030) & (Kg)

Table 102. Middle East, Africa and Latin America SGLT2 Inhibitor Revenue by Application (2019-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America SGLT2 Inhibitor Revenue by Application (2025-2030) & (US$ Million)

Table 104. Middle East, Africa and Latin America SGLT2 Inhibitor Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 105. Middle East, Africa and Latin America SGLT2 Inhibitor Revenue by Country (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America SGLT2 Inhibitor Revenue by Country (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America SGLT2 Inhibitor Sales by Country (2019-2024) & (Kg)

Table 108. Middle East, Africa and Latin America SGLT2 Inhibitor Sales by Country (2025-2030) & (Kg)

Table 109. Eli Lilly Company Information

Table 110. Eli Lilly Description and Major Businesses

Table 111. Eli Lilly SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 112. Eli Lilly SGLT2 Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. Eli Lilly Recent Developments

Table 114. Boehringer Ingelheim Company Information

Table 115. Boehringer Ingelheim Description and Major Businesses

Table 116. Boehringer Ingelheim SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 117. Boehringer Ingelheim SGLT2 Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Boehringer Ingelheim Recent Developments

Table 119. Johnson & Johnson Company Information

Table 120. Johnson & Johnson Description and Major Businesses

Table 121. Johnson & Johnson SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 122. Johnson & Johnson SGLT2 Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. Johnson & Johnson Recent Developments

Table 124. AstraZeneca Company Information

Table 125. AstraZeneca Description and Major Businesses

Table 126. AstraZeneca SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 127. AstraZeneca SGLT2 Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. AstraZeneca Recent Developments

Table 129. Merck Company Information

Table 130. Merck Description and Major Businesses

Table 131. Merck SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 132. Merck SGLT2 Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications

Table 133. Merck Recent Developments

Table 134. Pfizer Company Information

Table 135. Pfizer Description and Major Businesses

Table 136. Pfizer SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 137. Pfizer SGLT2 Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications

Table 138. Pfizer Recent Developments

Table 139. Key Raw Materials Lists

Table 140. Raw Materials Key Suppliers Lists

Table 141. SGLT2 Inhibitor Distributors List

Table 142. SGLT2 Inhibitor Customers List

Table 143. SGLT2 Inhibitor Market Trends

Table 144. SGLT2 Inhibitor Market Drivers

Table 145. SGLT2 Inhibitor Market Challenges

Table 146. SGLT2 Inhibitor Market Restraints

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. SGLT2 Inhibitor Product Picture

Figure 2. Global SGLT2 Inhibitor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global SGLT2 Inhibitor Market Share by Type in 2023 & 2030

Figure 4. Dapagliflozin Product Picture

Figure 5. Canagliflozin Product Picture

Figure 6. Empagliflozin Product Picture

Figure 7. Other Product Picture

Figure 8. Global SGLT2 Inhibitor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global SGLT2 Inhibitor Market Share by Application in 2023 & 2030

Figure 10. Hospital Pharmacies

Figure 11. Retail Pharmacies

Figure 12. SGLT2 Inhibitor Report Years Considered

Figure 13. Global SGLT2 Inhibitor Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global SGLT2 Inhibitor Revenue 2019-2030 (US$ Million)

Figure 15. Global SGLT2 Inhibitor Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global SGLT2 Inhibitor Revenue Market Share by Region (2019-2030)

Figure 17. Global SGLT2 Inhibitor Sales 2019-2030 ((Kg)

Figure 18. Global SGLT2 Inhibitor Sales Market Share by Region (2019-2030)

Figure 19. US & Canada SGLT2 Inhibitor Sales YoY (2019-2030) & (Kg)

Figure 20. US & Canada SGLT2 Inhibitor Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe SGLT2 Inhibitor Sales YoY (2019-2030) & (Kg)

Figure 22. Europe SGLT2 Inhibitor Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China SGLT2 Inhibitor Sales YoY (2019-2030) & (Kg)

Figure 24. China SGLT2 Inhibitor Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) SGLT2 Inhibitor Sales YoY (2019-2030) & (Kg)

Figure 26. Asia (excluding China) SGLT2 Inhibitor Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America SGLT2 Inhibitor Sales YoY (2019-2030) & (Kg)

Figure 28. Middle East, Africa and Latin America SGLT2 Inhibitor Revenue YoY (2019-2030) & (US$ Million)

Figure 29. The SGLT2 Inhibitor Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 30. The Top 5 and 10 Largest Manufacturers of SGLT2 Inhibitor in the World: Market Share by SGLT2 Inhibitor Revenue in 2023

Figure 31. Global SGLT2 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 32. Global SGLT2 Inhibitor Sales Market Share by Type (2019-2030)

Figure 33. Global SGLT2 Inhibitor Revenue Market Share by Type (2019-2030)

Figure 34. Global SGLT2 Inhibitor Sales Market Share by Application (2019-2030)

Figure 35. Global SGLT2 Inhibitor Revenue Market Share by Application (2019-2030)

Figure 36. US & Canada SGLT2 Inhibitor Sales Market Share by Type (2019-2030)

Figure 37. US & Canada SGLT2 Inhibitor Revenue Market Share by Type (2019-2030)

Figure 38. US & Canada SGLT2 Inhibitor Sales Market Share by Application (2019-2030)

Figure 39. US & Canada SGLT2 Inhibitor Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada SGLT2 Inhibitor Revenue Share by Country (2019-2030)

Figure 41. US & Canada SGLT2 Inhibitor Sales Share by Country (2019-2030)

Figure 42. U.S. SGLT2 Inhibitor Revenue (2019-2030) & (US$ Million)

Figure 43. Canada SGLT2 Inhibitor Revenue (2019-2030) & (US$ Million)

Figure 44. Europe SGLT2 Inhibitor Sales Market Share by Type (2019-2030)

Figure 45. Europe SGLT2 Inhibitor Revenue Market Share by Type (2019-2030)

Figure 46. Europe SGLT2 Inhibitor Sales Market Share by Application (2019-2030)

Figure 47. Europe SGLT2 Inhibitor Revenue Market Share by Application (2019-2030)

Figure 48. Europe SGLT2 Inhibitor Revenue Share by Country (2019-2030)

Figure 49. Europe SGLT2 Inhibitor Sales Share by Country (2019-2030)

Figure 50. Germany SGLT2 Inhibitor Revenue (2019-2030) & (US$ Million)

Figure 51. France SGLT2 Inhibitor Revenue (2019-2030) & (US$ Million)

Figure 52. U.K. SGLT2 Inhibitor Revenue (2019-2030) & (US$ Million)

Figure 53. Italy SGLT2 Inhibitor Revenue (2019-2030) & (US$ Million)

Figure 54. Russia SGLT2 Inhibitor Revenue (2019-2030) & (US$ Million)

Figure 55. China SGLT2 Inhibitor Sales Market Share by Type (2019-2030)

Figure 56. China SGLT2 Inhibitor Revenue Market Share by Type (2019-2030)

Figure 57. China SGLT2 Inhibitor Sales Market Share by Application (2019-2030)

Figure 58. China SGLT2 Inhibitor Revenue Market Share by Application (2019-2030)

Figure 59. Asia SGLT2 Inhibitor Sales Market Share by Type (2019-2030)

Figure 60. Asia SGLT2 Inhibitor Revenue Market Share by Type (2019-2030)

Figure 61. Asia SGLT2 Inhibitor Sales Market Share by Application (2019-2030)

Figure 62. Asia SGLT2 Inhibitor Revenue Market Share by Application (2019-2030)

Figure 63. Asia SGLT2 Inhibitor Revenue Share by Region (2019-2030)

Figure 64. Asia SGLT2 Inhibitor Sales Share by Region (2019-2030)

Figure 65. Japan SGLT2 Inhibitor Revenue (2019-2030) & (US$ Million)

Figure 66. South Korea SGLT2 Inhibitor Revenue (2019-2030) & (US$ Million)

Figure 67. China Taiwan SGLT2 Inhibitor Revenue (2019-2030) & (US$ Million)

Figure 68. Southeast Asia SGLT2 Inhibitor Revenue (2019-2030) & (US$ Million)

Figure 69. India SGLT2 Inhibitor Revenue (2019-2030) & (US$ Million)

Figure 70. Middle East, Africa and Latin America SGLT2 Inhibitor Sales Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America SGLT2 Inhibitor Revenue Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America SGLT2 Inhibitor Sales Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America SGLT2 Inhibitor Revenue Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America SGLT2 Inhibitor Revenue Share by Country (2019-2030)

Figure 75. Middle East, Africa and Latin America SGLT2 Inhibitor Sales Share by Country (2019-2030)

Figure 76. Brazil SGLT2 Inhibitor Revenue (2019-2030) & (US$ Million)

Figure 77. Mexico SGLT2 Inhibitor Revenue (2019-2030) & (US$ Million)

Figure 78. Turkey SGLT2 Inhibitor Revenue (2019-2030) & (US$ Million)

Figure 79. Israel SGLT2 Inhibitor Revenue (2019-2030) & (US$ Million)

Figure 80. GCC Countries SGLT2 Inhibitor Revenue (2019-2030) & (US$ Million)

Figure 81. SGLT2 Inhibitor Value Chain

Figure 82. SGLT2 Inhibitor Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global SGLT 2 Inhibitors for Type 2 Diabetes Treatment Market Research Report 2025

Global Sodium dependent Glucose Co transporter 2 SGLT2 Market Research Report 2024

Global Empagliflozin Tablets Market Research Report 2025

Cancer Growth Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tofogliflozin Market Research Report 2025

Global Gastric Antisecretory Drug Market Insights Forecast to 2030

Global Sodium Glucose Cotransporter 2 SGLT 2 Inhibitors Market Insights Forecast to 2030

EGFR Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dapagliflozin Tablets Market Research Report 2024

Global EZH2 Inhibitor Market Research Report 2024

Circulating Galectin Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Anti Diabetic Drug Market Insights Forecast to 2030

Global HDAC histone deacetylase Inhibitor Market Insights Forecast to 2030

Global Gastric Inhibitory Polypeptide Receptor Market Research Report 2024

Global FLT3 Inhibitor Market Research Report 2025

Global HER2 Inhibitors Market Research Report 2024

Global Sitagliptin Tablet Market Research Report 2025

Global Glutamate Antagonist Market Research Report 2025

Global Galactoarabinan Market Insights Forecast to 2030

RELATED REPORTS

Global Ibuprofen Sodium API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30X13296

Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Enteric Gelatin Hollow Capsule Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11U13426

Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Argatroban Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-16160

Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Contrast Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-10G2665

Fri Mar 21 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions